Navigation Links
Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting
Date:4/26/2009

imal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.

SCHERING-PLOUGH DISCLOSURE NOTICE: The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the potential market for PEGINTRON and REBETOL. Forward-looking statements relate to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering-Plough's forward-looking statements, including uncertainties in the regulatory process, among other uncertainties. For further details about these and other factors that may impact the forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Item 1A "Risk Factors" in Schering-Plough's 2008 10-K, filed Feb. 27, 2009.

Endnotes

1. Bruix J, Poynard T, et al. PEGINTRON Maintenance Therapy in Cirrhotic (Metavir F4) HCV Patients Who Failed to Respond to Interferon/Ribavirin (IR) Therapy: Final Results of the EPIC3 Cirrhosis Maintenance Trial. Oral presentation at: 44th European Association for the Study of the Liver (EASL); April 22-26, Copenhagen, Denmark.

2. Buti M, Esteban R, et al. Extended Treatment Duration in Chronic Hepatitis C Genotype 1-Infected Slow-Responders: Final Results of the SUCCESS Study. Oral presentation at: 44th annual meeting of the European Association for the Study of the Liver (EASL); April 22-26, Copenhagen, Denmark.

3. SVR is defined as achievement of u
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
2. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
3. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
4. Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA
5. Schering-Plough Reports Top-Line Results of the IDEAL Study
6. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
7. Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients
8. Schering-Plough Announces Imperfect Contraceptive Use Impacts Womens Emotional Well-Being
9. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
10. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
11. Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015   Eli Lilly and Company ... ) will host a webcast on June 11 to discuss ... baricitinib in rheumatoid arthritis. Data from these two trials, RA-BEACON and ... Programme for the EULAR Congress 2015 in Rome, ... from 10:00 to11:00 a.m. Eastern Daylight Time. The live audio ...
(Date:5/28/2015)... 28, 2015  Merck KGaA, Darmstadt, ... and top-quality high-tech products in healthcare, life science ... agreement with the fertility technologies expert Genea Biomedx, ... and helping couples create families. With this partnership, ... a global market leader in drugs for Assisted ...
(Date:5/28/2015)... CHICAGO , May 28, 2015  The ... left health plans and employer groups scrambling to ... by a major managed care plan, retail pharmacy ... United Healthcare,s $13.3 billion purchase of Catamaran, Rite ... recent announcement to purchase Omni-Care for $10 billion ...
Breaking Medicine Technology:Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data 2Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data 3Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 2Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 3Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 4Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 2Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 3
... a global provider of comprehensive sample management solutions ... logistics and virtual sample intelligence, will host its ... May 2012 in Brussels, Belgium from 16:00 – ... Dr. Graham Hughes, Consultant in Pharmaceutical Development and ...
...  NxStage® Medical, Inc. (Nasdaq: NXTM ), ... announced that former NxStage® System One™ patient Nikolas ... following four successful years of more frequent home ... http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) The freedom ...
Cached Medicine Technology:BioStorage Technologies to Lead Discussion on the Value of a Comprehensive Sample Management Strategy 2Former NxStage Patient Nikolas Gieske Celebrates Kidney Transplant 2Former NxStage Patient Nikolas Gieske Celebrates Kidney Transplant 3
(Date:5/28/2015)... 2015 On Monday, June 1, KORT, ... 160 Frankfort Road in Shelbyville, Kentucky . Clinic Director, Chad ... well as treat patients , “ Shelbyville is a ... , local clinic to better serve the residents of Shelby ... experience as trouble-free as possible by providing accessible and immediate ...
(Date:5/28/2015)... 2015 The USC Verdugo Hills Hospital Wound ... for a decade with a current average healing rate of ... and Wound Care Advantage to provide in-patient wound care. This ... a drop in the rate of hospital-acquired pressure ulcers from ... a complex undertaking that can frighten patients and caregivers who ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Success ... 351(k) Application Process, **FDAnews Webinar**, June 23, 2015 ... [http://www.fdanews.com/BiosimilarsApproval , On June 23, 2015, FDAnews ... two leading intellectual property attorneys from the international ... Strategies for Biosimilars Approval: A Roadmap to the ...
(Date:5/28/2015)... NJ (PRWEB) May 28, 2015 Three years ... new location for his Shore Vascular & Vein Center! ... the circulatory system. It is his mission to provide ... and respect. , Dr. Jeffrey Gosin is Board ... of the University of Pennsylvania and Jefferson Medical College. He ...
(Date:5/28/2015)... Ross A. Clevens, MD, FACS, Brevard’s board ... as the new marketing director for Clevens Face and ... marketing and promotional events for the practice. Beard has ... compelling marketing strategies to achieve targeted results. Prior to ... guest communication manager at the Walt Disney World Resort ...
Breaking Medicine News(10 mins):Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 2Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 3Health News:USC Verdugo Hills Hospital Wound Care Team Provides Outstanding Healing Results 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 3Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 2Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 3Health News:Clevens Face and Body Specialists Welcomes Teresa Beard as Marketing Director 2
... N.J., Oct. 19 Roundstone Healthcare Funding has brought ... ) the flexible and value added tools organizations need ... a focus on public entities, benefit consultants and other ... a range of services: OPEB liability estimation, dedicated ...
... PEMBROKE, Bermuda, Oct. 19 ... announced today that Allied World,U.S., Susan Chmieleski, Senior Vice ... 2009 American Society for Healthcare and Risk,Management (ASHRM) annual ... is titled ,Ambulatory Surgery Centers: Does Your Risk Program,Work?, ...
... with lupus, rheumatoid arthritis , MONDAY, Oct. 19 ... women,s exposure to household insecticides -- including roach and ... and lupus. , The scientist did not find a ... and it,s possible that the women have something else ...
... KANSAS CITY, Kan., Oct. 19 Premier Plastic Surgery of Kansas ... years, has redesigned its extensive website to include a separate ... Centre, and a Plastic Surgery Blog that features breaking news ... American Society for Aesthetic Plastic Surgery, cosmetic surgery for males ...
... ... next decade. The global online business hosting provider today announced the 10th anniversary of its ... free setup on all available Managed Hosting plans during September 2009. , ... Southampton, UK (PRWEB) October 19, 2009 ...
... ... Effective on October 19, 2009, ERISAclaim.com is expanding its Litigation ... recoupment dispute and claim denial litigations in the $6 trillion healthcare ... the insurance and benefit payment for non-Medicare claims for 35 years, ...
Cached Medicine News:Health News:Allied World's Susan Chmieleski to Speak at American Society for Healthcare Risk Management (ASHRM) Annual Conference and Exhibition 2Health News:Allied World's Susan Chmieleski to Speak at American Society for Healthcare Risk Management (ASHRM) Annual Conference and Exhibition 3Health News:Household Insecticides May Be Linked to Autoimmune Diseases 2Health News:Household Insecticides May Be Linked to Autoimmune Diseases 3Health News:Premier Plastic Surgery of Kansas City's Extended Website Provides Latest Information on Male and Female Cosmetic Surgery 2Health News:Premier Plastic Surgery of Kansas City's Extended Website Provides Latest Information on Male and Female Cosmetic Surgery 3Health News:Premier Plastic Surgery of Kansas City's Extended Website Provides Latest Information on Male and Female Cosmetic Surgery 4Health News:PEER 1 Celebrates 10th Anniversary 2Health News:PEER 1 Celebrates 10th Anniversary 3Health News:ERISAclaim.com Announced the Expansion of its ERISA Litigation Support for the Healthcare Claims in Response to Increasing High Demand from the $6 Trillion Healthcare Denial Management Market 2Health News:ERISAclaim.com Announced the Expansion of its ERISA Litigation Support for the Healthcare Claims in Response to Increasing High Demand from the $6 Trillion Healthcare Denial Management Market 3Health News:ERISAclaim.com Announced the Expansion of its ERISA Litigation Support for the Healthcare Claims in Response to Increasing High Demand from the $6 Trillion Healthcare Denial Management Market 4
... Compact is a fully ... analyser for clotting, photometric ... .coagulation tests.The medium-throughput analyser ... primary tubes, 45 reagents ...
... MPD Lancets are designed with Shallow Point ... thin gauge needle with its shallow-angled edges ... painful penetration without tearing the skin. The ... easy to grip, even for patients with ...
... Plus Safety Lancets help protect healthcare ... stick injuries and cross-contamination. Designed to ... needlestick safety, the needle is shielded ... Haemolance Plus features automatic lockout after ...
... offer a complete range of needle sizes to ... meters can be obtained with any skin type, ... and choice of needle diameters enable users to ... or tissue damage. This makes it easier to ...
Medicine Products: